Strong expression of hormonal receptors including androgen, estrogen, and progesterone receptors are reported in aggressive sweat gland carcinomas, and management with antiestrogen therapies such as tamoxifen can be effective.4 The gene discussed is NR4A1; the disease is sweat gland carcinoma.